Triple Negative Breast Cancer (TNBC), which accounts for 12–24% of all breast carcinomas, is defined by the lack of expression of estrogen, progesterone receptors (ER, PgR) and HER2 [9]. This evidence concerns the gene PGR and triple-negative breast carcinoma.